Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Bases de dados
Tipo de documento
Intervalo de ano de publicação
1.
Otolaryngol Head Neck Surg ; 170(2): 447-456, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38104320

RESUMO

OBJECTIVE: Postradiation nasopharyngeal necrosis (PRNN) frequently develops after second-course radiotherapy for nasopharyngeal carcinoma (NPC). PRNN can lead to internal carotid artery (ICA) massive hemorrhage due to ICA rupture, resulting in sudden death. This study aims to explore the pretreatment of the ICA to prevent fatal massive hemorrhage in PRNN patients. STUDY DESIGN: Retrospective cohort study. SETTING: Sun Yat-sen University Cancer Center. METHODS: Patients diagnosed with NPC and PRNN from January 2010 to September 2022 were included. The Cox proportional hazards regression analysis was performed to analyze risk factors for massive hemorrhage and survival. A nomogram was developed to integrate prognostic models and perform parameter calibration. RESULTS: Two hundred and fifty-four PRNN patients were included in this study. Prophylactic ICA occlusion significantly reduced the risk of ICA hemorrhage compared to no prophylactic ICA occlusion (3.6% vs 40.6%, P < .001). Surgical repair on necrosis significantly prevented hemorrhage and improved survival. The nomogram, incorporating the above 2 factors and the nearest distance from necrosis to ICA ≤ 3 mm, exhibited excellent discriminative ability for hemorrhage. We identified 3 high-risk factors that indicate the need for prophylactic ICA management in PRNN patients: (1) exposure of ICA by rhinoscopy; (2) signs of ICA erosion on MRA scanning; (3) the depth of soft tissue coverage surrounding the ICA wall within the necrotic cavity is less than 3 mm on magnetic resonance imaging. CONCLUSION: We have identified 3 high-risk factors for PRNN patients that necessitate prophylactic ICA management. These findings are expected to contribute to improving the quality of life and overall survival of PRNN patients.


Assuntos
Neoplasias Nasofaríngeas , Humanos , Neoplasias Nasofaríngeas/radioterapia , Neoplasias Nasofaríngeas/patologia , Estudos Retrospectivos , Qualidade de Vida , Artéria Carótida Interna/patologia , Carcinoma Nasofaríngeo , Necrose/etiologia , Necrose/prevenção & controle , Hemorragia/etiologia , Hemorragia/prevenção & controle
2.
J Plast Reconstr Aesthet Surg ; 75(9): 3014-3021, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35710777

RESUMO

BACKGROUND: Mastectomy skin flap necrosis is a major complication of skin- or nipple-sparing mastectomy. Indocyanine green angiography (ICGA) is a novel technology that can identify flaps at risk of necrosis, but there is paucity of cost-effectiveness data particularly in the Australian context. We evaluated its cost-effectiveness in breast reconstruction surgery. METHODS: Single-institution retrospective study of 295 implant-based breast reconstructions using ICGA compared with 228 reconstructions without ICGA from 2015 to 2020. Costs were calculated using Medicare item numbers and micro-costing analysis. Break-even point analysis determined the number needed to break-even. Cost-utility analysis compared probabilities of ischaemic complications and utility estimates derived from surveys of surgeons to fit into a decision model. RESULTS: There were 295 breast reconstructions using ICGA with a total cost of AU$164,657. The average cost of treating an ischaemic complication was AU$21,375. Use of ICGA reduced the ischaemic complication rate from 14.9% to 8.8%. Ischaemic complications were prevented in 18 breasts resulting in gross cost savings of AU$384,745 and net savings of AU$220,088. Three hundred eighteen cases using ICGA are needed to break-even. The decision model demonstrated a baseline cost difference of AU$1,179, a quality-adjusted life-years (QALY) difference of 1.77, and an incremental cost-utility ratio (ICUR) of AU$656 per QALY favouring ICGA. CONCLUSIONS: Routine use of ICGA during implant-based breast reconstruction is a cost-effective intervention for the reduction of ischaemic complications in the Australian setting. ICGA use was associated with a gain of 1.77 additional years of perfect health at a cost of AU$656 more per year.


Assuntos
Neoplasias da Mama , Mamoplastia , Idoso , Angiografia/métodos , Austrália , Análise Custo-Benefício , Feminino , Humanos , Verde de Indocianina , Mamoplastia/métodos , Mastectomia , Medicare , Necrose/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle , Estudos Retrospectivos , Estados Unidos
3.
J Reconstr Microsurg ; 35(7): 471-478, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30791063

RESUMO

BACKGROUND: Mastectomy flap necrosis is the source of considerable morbidity and cost following breast reconstruction. A great deal of effort has been put forth to predicting and even preventing its incidence intraoperatively. METHODS: A review of the literature was performed evaluating the evidence of mastectomy skin flap perfusion technologies. RESULTS: Multiple technologies have leveraged spectroscopy and/or angiography to provide real-time assessment of flap perfusion, including indocyanine green, fluorescein, and light-based devices. CONCLUSION: This manuscript endeavors to review the evidence on mastectomy skin flap perfusion analysis, highlighting the benefits, and downsides of the current technologies and identifying exciting areas of future research and development.


Assuntos
Neoplasias da Mama/cirurgia , Mastectomia/métodos , Complicações Pós-Operatórias/prevenção & controle , Retalhos Cirúrgicos/irrigação sanguínea , Corantes , Feminino , Angiofluoresceinografia , Humanos , Verde de Indocianina , Necrose/prevenção & controle , Perfusão , Análise Espectral , Retalhos Cirúrgicos/patologia
4.
Ann Plast Surg ; 76 Suppl 4: S336-9, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26835821

RESUMO

INTRODUCTION: Skin flap necrosis after mastectomy can be a devastating complication significantly affecting patient outcomes. Routine vascular analysis (fluorescein or laser angiography) of mastectomy skin flaps in all patients has been advocated but is of questionable cost-effectiveness. The purpose of this study was to identify the incidence and causative risk factors for mastectomy skin flap necrosis and thereby calculate the fiscal reality of intraoperative vascular screening. METHODS: This is an institutional review board-approved retrospective study of all patients from 2007 to 2013 who underwent mastectomy related to breast cancer. Skin flap necrosis was defined as major if it necessitated return to the operating room. Data analysis was done for determination of causative factors of necrosis, including age, body mass index, smoking, previous irradiation, coronary artery disease, chronic obstructive pulmonary disorder, hypertension, gastroesophageal reflux disease, hyperlipidemia, obstructive sleep apnea, asthma, diabetes, thyroid disease, history of lumpectomy, and breast reduction or augmentation. During this time, intraoperative vascular screening was not done. RESULTS: Five hundred eighty-one patients underwent 616 mastectomies with a total of 34 necrotic events (5.5%)-16 major and 18 minor. Analyses via Student t tests, univariate analyses, χ testing, and logistic regression showed that history of smoking was the only patient factor associated with postoperative necrosis (P = 0.008). More frequently represented in the necrosis group, but without statistical significance, are previous lumpectomy (P = 0.069) and immediate reconstruction (P = 0.078).For the entire study period, the actual cost to the hospital for major necrotic events was $7,123.10 or $445.19 for each of the 16 major necrotic events and $209.50 for all 34 necrotic events. Per-patient cost-effective screening would need to be less than $11.54 for all patients, $100.33 for highest risk patients (smokers), and $21.65 for highest risk patients (smokers, previous lumpectomy, and immediate reconstruction). CONCLUSIONS: Vascular screening other than clinical judgment of all patients is not cost effective. However, intraoperative vascular evaluation of high-risk patients is recommended before reconstruction and/or closure. These financial data that incorporate true costs and revenue can guide the use of newer, more expensive technology such as laser angiography and can be extrapolated to other institutions.


Assuntos
Mastectomia , Complicações Pós-Operatórias/etiologia , Pele/patologia , Retalhos Cirúrgicos/patologia , Angiografia , Análise Custo-Benefício , Feminino , Florida , Seguimentos , Custos Hospitalares/estatística & dados numéricos , Humanos , Incidência , Cuidados Intraoperatórios/economia , Modelos Logísticos , Necrose/economia , Necrose/epidemiologia , Necrose/etiologia , Necrose/prevenção & controle , Complicações Pós-Operatórias/economia , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/prevenção & controle , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Pele/irrigação sanguínea , Pele/diagnóstico por imagem , Retalhos Cirúrgicos/irrigação sanguínea
5.
Poult Sci ; 95(4): 780-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26740132

RESUMO

Development of viable alternatives to antibiotics to control necrotic enteritis (NE) caused by Clostridium perfringensis becoming urgent for chicken production due to pessures on poultry producers to limit or stop the use of antibiotics in feed. We have previously identified citral as a potential alternative to antibiotics. Citral has strong antimicrobial activity and can be encasupsulated in a powder form for protection from loss during feed processing, storage, and intestinal delivery. In the present study, encapsulated citral was evaluated both in vitro and in vivo for its antimicrobial activity against C. perfringens Encapsulation did not adversely affect the antimicrobial activity of citral. In addition, encapsulated citral was superior to the unencapsulated form in retaining its antimicrobial activity after treatment with simulated gastrointestinal fluids and in the presence of chicken intestinal digesta. In addition, the higher antimicrobial activity of encapsulated citral was confirmed in digesta samples from broilers that had been gavaged with encapsulated or unencapsulated citral. In broilers infected with C. perfringens, the diets supplemented with encapsualted citral at both 250 and 650 µg/g significantly reduced intestinal NE lesions, which was comparable to the effect of bacitracin- and salinomycin-containing diets. However, supplementation with the encapsulated citral appeared to have no significant impact on the intestinal burden of Lactobacillus These data indicate that citral can be used to control NE in chickens after proper protection by encapsulation.


Assuntos
Infecções por Clostridium/veterinária , Clostridium perfringens/fisiologia , Enterite/veterinária , Monoterpenos/farmacologia , Óleos Voláteis/farmacologia , Doenças das Aves Domésticas/prevenção & controle , Monoterpenos Acíclicos , Ração Animal/análise , Animais , Galinhas , Infecções por Clostridium/microbiologia , Infecções por Clostridium/prevenção & controle , Dieta/veterinária , Suplementos Nutricionais/análise , Enterite/microbiologia , Enterite/prevenção & controle , Monoterpenos/administração & dosagem , Necrose/microbiologia , Necrose/prevenção & controle , Necrose/veterinária , Óleos Voláteis/administração & dosagem , Doenças das Aves Domésticas/microbiologia
6.
J Reconstr Microsurg ; 29(1): 15-9, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23100086

RESUMO

One of the areas of interest within the discipline of reconstructive microsurgery is increasing the amount of tissue harvested along with a given pedicle and sustaining it. The aim of this study is to introduce moist heat postconditioning as a means to increase skin flap survival and evaluate its effectiveness. Eight white New Zealand rabbits weighing 2500 to 3000 g were separated into two groups. In both groups, the truncal flaps spanning four consecutive angiosomes were elevated bilaterally. Flaps were inset back afterwards, and to the flaps in the trial group moist heat was applied for 30 minutes. After 2 weeks, the flaps were photographed and flap survival ratios were calculated via ImageTool© software (University of Texas Health Science Center, San Antonio, Texas, USA). With an average necrosis ratio of 4.91% versus 37.31%, the flaps treated with moist heat displayed a significantly better survival rate (p = 0.000). This study presenting our new method demonstrates that application of moderate moist heat right after the flap inset provides a significant increase in flap survival and introduces a noninvasive, cost-effective, and safe method for clinical use.


Assuntos
Sobrevivência de Enxerto , Temperatura Alta , Umidade , Microcirurgia/métodos , Neovascularização Fisiológica , Retalhos Cirúrgicos/patologia , Animais , Análise Custo-Benefício , Necrose/prevenção & controle , Coelhos , Temperatura Cutânea , Retalhos Cirúrgicos/irrigação sanguínea
7.
Vestn Khir Im I I Grek ; 171(3): 98-101, 2012.
Artigo em Russo | MEDLINE | ID: mdl-22880443

RESUMO

In 52 rabbits a morphological assessment was made of regeneration of wounds of the liver and kidneys after their plasty with a seromuscle flap of the stomach on the vascular pedicle (26 rabbits), of hepatorhaphy and omentonephroplasty (26 rabbits) within the period from 1 to 360 days and was compared with literature data concerning reparation of the liver and kidney of the rabbit with the application of bio- and polymer materials for covering their wounds. The influence of plastic properties of the materials used on the productivity of the inflammatory-reparative process was established. In suturing the wounds of parenchymatous organs it is necessary to use plastic materials stimulating regeneration. The application of seromuscle flap of the stomach for these purposes improves the inflammatory-reparative process making it more productive as compared with bio- and polymer materials.


Assuntos
Materiais Biocompatíveis/uso terapêutico , Retalhos de Tecido Biológico , Rim , Fígado , Omento/transplante , Estômago/transplante , Animais , Retalhos de Tecido Biológico/efeitos adversos , Retalhos de Tecido Biológico/patologia , Retalhos de Tecido Biológico/fisiologia , Rim/lesões , Rim/cirurgia , Fígado/lesões , Fígado/cirurgia , Modelos Animais , Monitorização Fisiológica , Necrose/etiologia , Necrose/prevenção & controle , Coelhos , Transplante Autólogo/métodos , Resultado do Tratamento , Técnicas de Fechamento de Ferimentos/efeitos adversos , Cicatrização
8.
Pharm Biol ; 48(3): 253-9, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20645809

RESUMO

Honey-bee pollen mix (HBM) formulation is claimed to be effective for the treatment of asthma, bronchitis, cancers, peptic ulcers, colitis, various types of infections including hepatitis B, and rheumatism by the herb dealers in northeast Turkey. In the present study, in vivo antinociceptive, anti-inflammatory, gastroprotective and antioxidant effects of pure honey and HBM formulation were evaluated comparatively. HBM did not show any significant gastroprotective activity in a single administration at 250 mg/kg dose, whereas a weak activity was observed after three days of successive administration at 500 mg/kg dose. On the other hand, HBM displayed significant antinociceptive (p <0.01) and anti-inflammatory (p <0.01) activities at 500 mg/kg dose orally without inducing any apparent acute toxicity or gastric damage. HBM was also shown to possess potent antilipidperoxidant activity (p <0.01) at 500 mg/kg dose against acetaminophen-induced liver necrosis model in mice. On the other hand, pure honey did not exert any remarkable antinociceptive, anti-inflammatory and gastroprotective activity, but a potent antilipidperoxidant activity (p <0.01) was determined. Results have clearly proved that mixing pure honey with bee pollen significantly increased the healing potential of honey and provided additional support for its traditional use. Total phenolic and flavonoid contents of HBM were found to be 145 and 59.3 mg/100 g of honey, which were estimated as gallic acid and quercetin equivalents, respectively.


Assuntos
Apiterapia/métodos , Abelhas , Mel , Pólen , Analgésicos não Narcóticos/efeitos adversos , Analgésicos não Narcóticos/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/uso terapêutico , Antiulcerosos/efeitos adversos , Antiulcerosos/uso terapêutico , Antioxidantes/administração & dosagem , Antioxidantes/efeitos adversos , Antioxidantes/uso terapêutico , Apiterapia/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/patologia , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Feminino , Flavonoides/análise , Mel/análise , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Camundongos , Necrose/induzido quimicamente , Necrose/prevenção & controle , Fenóis/análise , Pólen/química , Ratos , Ratos Sprague-Dawley , Turquia
9.
Prev Vet Med ; 80(2-3): 193-208, 2007 Jul 16.
Artigo em Inglês | MEDLINE | ID: mdl-17391788

RESUMO

We summarised the challenges faced in an ex ante cost-benefit appraisal of United Kingdom government spending on disease surveillance for three notifiable fish diseases: infectious salmon anaemia (ISA), viral haemorrhagic septicaemia (VHS) and infectious haemorrhagic necrosis (IHN). We used a social cost-benefit analysis and adopted a national perspective. We compared costs of current public and private surveillance effort with the benefits stated in terms of the avoided private and social costs of potential disease outbreaks. Spending on ISA and VHS were predicted to be efficient; the benefit-cost ratios were always >or=3.2 for ISA and >or=5.8 for VHS for all nine scenarios examined for each infection. However, the benefit-cost ratio for IHN was predicted never to exceed 1.6, and was <1.0 in five of the nine scenarios-so spending on IHN would be harder to justify.


Assuntos
Doenças dos Peixes , Isavirus/isolamento & purificação , Novirhabdovirus/isolamento & purificação , Infecções por Orthomyxoviridae/veterinária , Infecções por Rhabdoviridae/veterinária , Animais , Análise Custo-Benefício , Doenças dos Peixes/economia , Doenças dos Peixes/epidemiologia , Doenças dos Peixes/prevenção & controle , Peixes , Necrose/economia , Necrose/epidemiologia , Necrose/prevenção & controle , Necrose/veterinária , Infecções por Orthomyxoviridae/economia , Infecções por Orthomyxoviridae/epidemiologia , Infecções por Orthomyxoviridae/prevenção & controle , Infecções por Rhabdoviridae/economia , Infecções por Rhabdoviridae/epidemiologia , Infecções por Rhabdoviridae/prevenção & controle , Salmão , Vigilância de Evento Sentinela/veterinária , Truta , Reino Unido/epidemiologia
10.
Toxicon ; 45(2): 171-8, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15626366

RESUMO

The role of the cytokines TNF-alpha, IL-1beta and IL-6 in the acute local pathological effects induced by Bothrops asper snake venom was assessed in mice. Intramuscular injection of this venom induced increments in IL-1beta and IL-6 in muscle, but no elevations of TNF-alpha were detected. Pentoxifylline (PTX), a methylxanthine derivative that inhibits the synthesis of TNF-alpha, and antibodies against these three cytokines were used to assess the role of these cytokines in venom-induced effects. As a control, PTX pretreatment was effective at abrogating lethality and serum TNF-alpha increments in mice subjected to endotoxemia induced by injection of Escherichia coli lipopolysaccharide, although it did not affect the increment in IL-1beta and IL-6 in such endotoxic model. PTX failed to reduce lethality, hemorrhage, myonecrosis, dermonecrosis and edema induced by B. asper venom. Moreover, pretreatment with anti-cytokine antibodies was also ineffective at reducing venom-induced myonecrosis and hemorrhage. It is concluded that TNF-alpha, IL-1beta and IL-6 do not have a significant role in the pathogenesis of the acute local pathological effects induced by B. asper venom in mice, although this does not exclude the possibility that these cytokines play a role in other aspects of venom-induced local pathology, as well as in the reparative and regenerative responses that take place after the onset of tissue damage.


Assuntos
Venenos de Crotalídeos/toxicidade , Interleucina-1/fisiologia , Interleucina-6/fisiologia , Fator de Necrose Tumoral alfa/fisiologia , Animais , Bothrops , Venenos de Crotalídeos/antagonistas & inibidores , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/prevenção & controle , Hemorragia/induzido quimicamente , Hemorragia/prevenção & controle , Interleucina-1/biossíntese , Interleucina-6/biossíntese , Dose Letal Mediana , Camundongos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Necrose/induzido quimicamente , Necrose/prevenção & controle , Pentoxifilina/farmacologia , Pele/efeitos dos fármacos , Fatores de Tempo , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/imunologia
11.
Hepatology ; 21(2): 561-9, 1995 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7843731

RESUMO

A dose of diquat below the amount injurious to selenium-replete animals causes lipid peroxidation and massive liver necrosis in selenium-deficient rats. The current study was undertaken to characterize the lipid peroxidation with respect to the liver injury and to correlate the presence of several selenoproteins with the protective effect of selenium. Lipid peroxidation was assessed by measurement of F2 isoprostanes. Diquat caused an increase in liver and plasma F2 isoprotanes. A gradient of these compounds was detected across the liver in some animals, indicating that this organ was a source of some of the plasma F2 isoprostanes. A time-course experiment showed that liver F2 isoprostane concentration increased before plasma alanine transaminase (ALT) levels rose. Selenium-deficient rats were injected with selenium doses from 2 to 50 micrograms/kg and studied 12 hours later. A dose of 10 micrograms/kg or more prevented diquat-induced lipid peroxidation and liver injury. This dose increased plasma selenoprotein P substantially, and a dose-response was present. Liver cellular and plasma glutathione peroxidase activities remained below 2% of their values in control rats for all selenium doses. In selenium-deficient rats given diquat, hepatic lipid peroxidation precedes hepatic necrosis and could therefore be an important mechanism of the necrosis. Selenoprotein P levels were increased by selenium injections, which protected against diquat injury, but glutathione peroxidase activity was not increased. This is consistent with selenoprotein P being the mediator of the selenium effect.


Assuntos
Peroxidação de Lipídeos , Fígado/metabolismo , Fígado/patologia , Proteínas/fisiologia , Selênio/deficiência , Animais , Tetracloreto de Carbono/farmacologia , Dinoprosta/biossíntese , Diquat , Relação Dose-Resposta a Droga , Masculino , Necrose/induzido quimicamente , Necrose/prevenção & controle , Proteínas/uso terapêutico , Ratos , Ratos Sprague-Dawley , Selenoproteína P , Selenoproteínas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA